In this issue:
- Frailty and ICI toxicity in melanoma
- Skin self-examination for screening for suspicious pigmented lesions
- RT and systemic therapy sequencing in melanoma with brain metastases
- Causes of death for patients with cutaneous SCC
- Anti-PD-1 ±ipilimumab after BRAF/MEK inhibition in BRAFmutated metastatic melanoma
- Adjuvant RT after clear-margin resection of T-stage cutaneous SCC reduces recurrence
- Anti-PD-1 and/or ipilimumab for acral melanoma
- Oral vitamin D pretreatment improves blue-light PDT for facial AK
- Adding atezolizumab to vemurafenib-cobimetinib for melanoma with CNS metastases
- Invasive cutaneous SCC risk after different AK treatments
Please login below to download this issue (PDF)